New scan could spot hidden heart risk in kidney patients
NCT ID NCT07585695
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a special heart scan (CZT-SPECT) can better predict heart attacks, strokes, and heart failure in people with chronic kidney disease. Current tests often miss heart problems in these patients. The study will follow 283 participants for two years to see if the scan's results match up with who has heart events.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CZT-SPECT imaging (a type of heart scan)
What this could lead to
If successful, this could lead to a better, non-invasive way to identify kidney patients at highest risk of heart problems, allowing earlier treatment.
What could go wrong
This is an observational study, not a treatment trial. The scan may not prove more useful than current methods, and results may not apply to all kidney patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE (CAD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Grenoble Alpes
La Tronche, France, 38700, France
Contact Phone: •••-•••-•••• Email: •••••@•••••